State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections

Ozcan Kayikcioglu; Sinan Bilgin; Goktug Seymenoglu; Artuner Deveci

doi:10.1159/000478993

State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections

Biomed Hub. 2017 Aug 5;2(2):1-5. doi: 10.1159/000478993. eCollection 2017 May-Aug.

Authors

Ozcan Kayikcioglu¹, Sinan Bilgin², Goktug Seymenoglu¹, Artuner Deveci³

Affiliations

¹ Department of Ophthalmology, Celal Bayar University, Manisa, Turkey.
² Department of Department of Ophthalmology, Medifema Hospital, Izmir, Turkey.
³ Department of Psychiatry, Hafsa Sultan Hospital, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.

Abstract

Background: To evaluate parameters on the state and trait anxiety scores of patients receiving intravitreal injections.

Methods: One hundred thirteen patients were included in the study. All subjects received intravitreal ranibizumab or bevacizumab injections. To measure the level of anxiety, Spielberg's State-Trait Anxiety Inventory questionnaire was used.

Results: The mean state anxiety scores were 45.19 ± 5.62 in experienced patients and 43.10 ± 6.62 in inexperienced patients (p = 0.078). The mean trait anxiety scores were 50.14 ± 6.62 in experienced patients and 49.17 ± 10.79 in inexperienced patients (p = 0.810). Additionally, there was no statistically significant difference in the state and trait anxiety scores between the male and female, employed, and retired patients (p > 0.05).

Conclusion: Anxiety may not show significant differences according to sociodemographic status. High anxiety scores found in this study also emphasize that health care providers should try to decrease anxiety levels during the course of treatment.

Keywords: Bevacizumab; Intravitreal injection; Ranibizumab; Status anxiety scores; Trait anxiety scores.